KLK3 and posterior cortical atrophy: A major challenge in PCa clinical management lies in the limitations of current diagnostic tests, such as serum prostate specific antigen (PSA) testing, digital rectal examination, and histopathologic grading of tissues, to discern between indolent and aggressive disease [5].